[HTML][HTML] Drug Repurposing Patent Applications October–December 2020

HAM Mucke - ASSAY and Drug Development Technologies, 2021 - liebertpub.com
Bromantane (adamantylbromphenylamine) is an anxiolytic psychostimulant developed and
used in Russia at doses of 50–100 mg for what used to be called neurasthenia. It also is a …

Drug Repurposing Patent Applications October–December 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2024 - liebertpub.com
Inventor: Qi X Applicant: Soochow University, Suzhou (China) Published: October 5, 2023
Mitoxantrone is an anthraquinone topoisomerase II inhibitor with a broad-spectrum …

Drug Repurposing Patent Applications July–September 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2023 - liebertpub.com
It has been found by the inventors that flunarizine, used in migraine prophylaxis, occlusive
peripheral vascular disease, and vertigo, causes mitochondria to enter the lysosomal …

Drug repurposing patent applications October–December 2016

HAM Mucke - ASSAY and Drug Development Technologies, 2017 - liebertpub.com
Desmopressin (1-desamino-8-D-arginine vasopressin; dDVAP) is a synthetic and
generically available antidiuretic peptide hormone that has been marketed for the treatment …

[HTML][HTML] Drug Repurposing Patent Applications January–March 2023

HAM Mucke - ASSAY and Drug Development Technologies, 2023 - liebertpub.com
Monensin A, a lipophilic polyether antibiotic isolated from Streptomyces cinnamonensis, is
used extensively in cattle and poultry industries to prevent coccidiosis. 1 Like other …

Drug Repurposing Patent Applications January–March 2024

HAM Mucke - ASSAY and Drug Development Technologies, 2024 - liebertpub.com
In a truly innovative discovery, the inventors have found that psoriasis might be orally
treatable with the gastroprokinetic, mosapride, and other 5-HT4 receptor agonists. While it is …

Drug Repurposing Patent Applications April–June 2019

HAM Mucke - ASSAY and Drug Development Technologies, 2020 - liebertpub.com
Febuxostat and topiroxostat are second-generation xanthine oxidase inhibitors that reduce
uric acid production. Febuxostat came into broad use as a treatment for hyperuricemia and …

Drug repurposing and available patent protection in Europe: backing necessary costs involved for eg clinical trials, manufacturing, marketing

J Mannaerts, B Bouma, M Korsten - RExPO22 - scienceopen.com
Drug repurposing–the strategy for developing a new clinical application of a known
investigational drug or drug approved for a different indication–bears high potential for …

Drug Repurposing Patent Applications March–June 2022

HAM Mucke - Assay and Drug Development Technologies, 2022 - liebertpub.com
Research into treatments for viral infections has traditionally focused on viral targets. This is
also true for RNA viruses, where common targets include viral RNA-dependent RNA …

Drug repurposing using real-world data

GSQ Tan, EK Sloan, P Lambert, CMJ Kirkpatrick… - Drug Discovery …, 2023 - Elsevier
Highlights•250 records, including 144 original studies, met the eligibility criteria for inclusion
in this review.•Studies evaluated repurposing mainly for cardiovascular disease, COVID-19 …